RUMORED BUZZ ON MBL77

Not all clients with CLL demand therapy. Even with all recent advances, the iwCLL however endorses watchful observation for patients with asymptomatic ailment.86 This recommendation is predicated on at least two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104